James N. Thomas

Chief Executive Officer and Founding Partner, Just Biotherapeutics

Over the course of his career, Jim as contributed to the advancement of many important therapeutics including Activase, Vectibix, Enbrel, Prolia/Xgeva and Repatha, as well as numerous biosimilar programs. Jim has built teams, departments and functions passionate about creating and using innovative technologies to deliver to the needs of patients. Just Biotherapeutics was set up to improve the access of medicine to patients worldwide.

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019